Research

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

The University has approved an academic affiliation with INOVA Health System and George Mason University.

The CvilleBioHub has been awarded over $80,000 from the GO Virginia initiative to expand and sustain the biotechnology ecosystem in the region.

The CvilleBioHub has been awarded over $80,000 from the GO Virginia initiative to expand and sustain the biotechnology ecosystem in the region.

UVA researchers propose that the business community can address sustainability challenges through innovation and development of new technologies.

UVA and UVA-Wise are considering recommendations for improving challenges faced by rural Virginians. The initiative is engaging additional Virginia colleges and universities, government agencies, and stakeholders across the state.

UVA and UVA-Wise are considering recommendations for improving challenges faced by rural Virginians. The initiative is engaging additional Virginia colleges and universities, government agencies, and stakeholders across the state.